Woodline Partners’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $798K | Sell |
712,650
-711,517
| -50% | -$797K | ﹤0.01% | 824 |
|
|
2025
Q1 | $1.13M | Buy |
1,424,167
+1,382
| +0.1% | +$1.09K | 0.01% | 755 |
|
|
2024
Q4 | $2.35M | Sell |
1,422,785
-1,642,962
| -54% | -$2.71M | 0.02% | 629 |
|
|
2024
Q3 | $10.7M | Buy |
3,065,747
+2,063,745
| +206% | +$7.22M | 0.09% | 279 |
|
|
2024
Q2 | $3.29M | Sell |
1,002,002
-890,000
| -47% | -$2.92M | 0.03% | 376 |
|
|
2024
Q1 | $13.9M | Buy |
1,892,002
+1,506,638
| +391% | +$11.1M | 0.13% | 217 |
|
|
2023
Q4 | $1.44M | Buy |
+385,364
| New | +$1.44M | 0.02% | 390 |
|
|
2023
Q3 | – | Sell |
-100,056
| Closed | -$476K | – | 636 |
|
|
2023
Q2 | $476K | Buy |
100,056
+52
| +0.1% | +$248 | 0.01% | 544 |
|
|
2023
Q1 | $570K | Sell |
100,004
-60,714
| -38% | -$346K | 0.01% | 518 |
|
|
2022
Q4 | $1.62M | Hold |
160,718
| – | – | 0.02% | 497 |
|
|
2022
Q3 | $3.6M | Hold |
160,718
| – | – | 0.05% | 354 |
|
|
2022
Q2 | $3.98M | Hold |
160,718
| – | – | 0.06% | 290 |
|
|
2022
Q1 | $6.23M | Sell |
160,718
-38,358
| -19% | -$1.49M | 0.1% | 221 |
|
|
2021
Q4 | $11.6M | Buy |
199,076
+46,119
| +30% | +$2.7M | 0.17% | 167 |
|
|
2021
Q3 | $9.07M | Buy |
152,957
+21,851
| +17% | +$1.3M | 0.15% | 173 |
|
|
2021
Q2 | $11.4M | Buy |
131,106
+4,746
| +4% | +$412K | 0.21% | 120 |
|
|
2021
Q1 | $10.4M | Buy |
+126,360
| New | +$10.4M | 0.23% | 114 |
|